Observational Study
Copyright ©The Author(s) 2020.
World J Diabetes. May 15, 2020; 11(5): 193-201
Published online May 15, 2020. doi: 10.4239/wjd.v11.i5.193
Table 1 Demographic, clinical and biochemical parameters of the study population vs controls
Obese subjectsControlsP value
Male/Female (n)21/819/210.3234
Age (yr)62.14 (10.19)44.60 (18.76)< 0.0001
BMI (kg/m2)35.75 (3.75)24.56 (1.78)< 0.0001
WC (cm)106.58 (13.27)96.38 (3.76)< 0.0001
FPG (mg/dL)117.56 (42.13)92.63 (7.60)0.0016
TC (mg/dL)228.66 (45.22)137.70 (20.46)< 0.0001
HDL-c (mg/dL)47.72 (12.68)66.23 (10.85)< 0.0001
LDL-c (mg/dL)141.78 (42.43)106.93 (15.93)< 0.0001
TG (mg/dL)156.98 (92.25)95.77 (20.22)0.0005
UA (mg/dL)4.44 (1.18)3.80 (0.92)0.0073
eGFR (mL/min/1.73 m2)68.49 (18.84)106.77 (17.75)< 0.0001
FORT (mmol/L H2O2)3.04 (0.36)2.03(0.14)< 0.0001
FORD (mmol/L Trolox)1.27 (0.13)1.87 (1.20)0.0072
Table 2 Demographic, clinical and biochemical parameters of obese type 2 diabetes mellitus subjects vs obese non-diabetic patients
T2DMObese non-diabetic subjectsP value
Male/Female (n)6/2715/540.7965
Age (yr)66.45 (9.78)60.07 (9.79)0.0027
BMI (kg/m2)36.66 (4.01)35.32 (3.57)0.0920
WC (cm)107.24 (13.91)106.26 (13.04)0.7286
FPG (mg/dL)153.32 (56.94)100.45 (13.91)< 0.0001
TC (mg/dL)231.92 (46.75)227.11 (44.74)0.6180
HDL-c (mg/dL)43.98 (10.48)49.51 (13.30)0.0384
LDL-c (mg/dL)137.54 (38.10)143.80 (44.47)0.4885
TG (mg/dL)149.41 (111.44)160.60 (82.18)0.5690
UA (mg/dL)4.70 (1.33)4.32 (1.10)0.1319
FORT (mmol/L H2O2)3.16 (0.39)2.99 (0.33)0.0233
FORD (mmol/L Trolox)0.67 (0.15)0.72 (0.14)0.0649